Page last updated: 2024-08-18

arginine vasopressin and Disease Exacerbation

arginine vasopressin has been researched along with Disease Exacerbation in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (12.50)	18.2507
2000's	11 (45.83)	29.6817
2010's	10 (41.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Golembiewska, E; Lindholm, B; Machowska, A; Stenvinkel, P	1
Akers, SR; Ansari, B; Chirinos, JA; Fedorova, OV; Hussain, A; Lakatta, EG; Lee, J; Mustafa, A; Oldland, G; Sardana, M; Wei, W	1
Horibata, Y; Kawasoe, Y; Murakami, T; Niwa, K; Tateno, S	1
Horie, S; Kawano, H; Lu, Y; Muto, S; Nakajima, A	1
Colwell, CS; Gad, L; Ghiani, CA; Hitchcock, ON; Kuljis, DA; Loh, DH; MacDowell Kaswan, Z	1
Cervenak, L; Csuka, D; Farkas, H; Jani, PK; Kajdácsi, E; Prohászka, Z; Varga, L	1
Bakker, SJ; Gansevoort, RT; van den Brand, JA; Wetzels, JF; Zittema, D	1
Branco, LG; Oliveira-Pelegrin, GR; Ravanelli, MI; Rocha, MJ	1
Ishida, K; Kamata, K; Kobayashi, T; Matsumoto, T; Nakayama, N	1
Torres, VE	1
Barash, I; Goldfarb, DS; Ponda, MP; Skolnik, EY	1
Akahoshi, Y; Fujiki, H; Iwanaga, Y; Miyazaki, S; Morooka, H; Nakano, Y; Takase, T; Tamaki, Y	1
Goldsmith, SR	2
Adams, KF; Barbagelata, A; Elkayam, U; Gattis, WA; Gheorghiade, M; O'Connor, CM; Orlandi, C	1
Gheorghiade, M	1
Dünser, MW; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Ulmer, H; Wenzel, V	1
Cotter, G; Dittrich, HC; Gheorghiade, M; Metra, M; Milo-Cotter, O	1
Benedict, C; Francis, G; Johnstone, D; Kirlin, PC; Kubo, S; Liang, CS; Nicklas, J; Probstfield, J; Shelton, BJ; Yusuf, S	1
Saito, T	1
Bankir, L; Bouby, N; Hassler, C	1
Cecioni, I; Costoli, A; Galanti, G; Modesti, PA; Poggesi, L; Serneri, GG	1
Gómez, JM; Navarro, MA; Ramón, JM; Rosel, P; Sahún, M; Soler, J; Villabona, C	1
Anderson, AS; Ward, RP	1

Reviews

4 review(s) available for arginine vasopressin and Disease Exacerbation

Article	Year
Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease. Current protein & peptide science, 2017, Volume: 18, Issue:12 Topics: Adrenocorticotropic Hormone; Arginine Vasopressin; Biomarkers; Disease Progression; Female; Gene Expression Regulation; Glomerular Filtration Rate; Glycopeptides; Humans; Hypothalamus; Kidney Failure, Chronic; Male; Prognosis; Receptors, Vasopressin; Sex Factors; Signal Transduction; Vasopressins	2017
Vasopressin receptor antagonists: mechanisms of action and potential effects in heart failure. Cleveland Clinic journal of medicine, 2006, Volume: 73 Suppl 2 Topics: Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Disease Progression; Heart Failure; Humans; Hyponatremia; Treatment Outcome; Vasopressins	2006
Fluid overload in acute heart failure--re-distribution and other mechanisms beyond fluid accumulation. European journal of heart failure, 2008, Volume: 10, Issue:2 Topics: Arginine Vasopressin; Arteries; Disease Progression; Edema, Cardiac; Elasticity; Heart Failure; Humans; Kidney Failure, Chronic; Lung; Pulmonary Edema; Renin-Angiotensin System; Vascular Resistance; Vasodilator Agents; Water-Electrolyte Imbalance	2008
Slowing the progression of CHF. Drug therapy to correct neurohormonal abnormalities. Postgraduate medicine, 2001, Volume: 109, Issue:3 Topics: Adrenergic beta-Antagonists; Age Distribution; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Atrial Natriuretic Factor; Disease Progression; Family Practice; Heart Failure; Hemodynamics; Humans; Mineralocorticoid Receptor Antagonists; Primary Health Care; Renin-Angiotensin System; United States; Ventricular Dysfunction, Left	2001

Trials

2 trial(s) available for arginine vasopressin and Disease Exacerbation

Article	Year
A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease. Clinical journal of the American Society of Nephrology : CJASN, 2010, Volume: 5, Issue:4 Topics: Adult; Arginine Vasopressin; Biomarkers; Cyclic AMP; Disease Progression; Down-Regulation; Drinking; Female; Fluid Therapy; Humans; Male; Osmolar Concentration; Pilot Projects; Polycystic Kidney, Autosomal Dominant; Time Factors; Treatment Outcome; Water-Electrolyte Balance	2010
Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure. American heart journal, 2003, Volume: 145, Issue:2 Suppl Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Progression; Double-Blind Method; Heart Failure; Hospitalization; Humans; Patient Selection; Prospective Studies; Receptors, Vasopressin; Research Design; Tolvaptan	2003

Article

Year

A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease.

Clinical journal of the American Society of Nephrology : CJASN, 2010, Volume: 5, Issue:4

Topics: Adult; Arginine Vasopressin; Biomarkers; Cyclic AMP; Disease Progression; Down-Regulation; Drinking; Female; Fluid Therapy; Humans; Male; Osmolar Concentration; Pilot Projects; Polycystic Kidney, Autosomal Dominant; Time Factors; Treatment Outcome; Water-Electrolyte Balance

2010

Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure.

American heart journal, 2003, Volume: 145, Issue:2 Suppl

Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Progression; Double-Blind Method; Heart Failure; Hospitalization; Humans; Patient Selection; Prospective Studies; Receptors, Vasopressin; Research Design; Tolvaptan

2003

Other Studies

18 other study(ies) available for arginine vasopressin and Disease Exacerbation

Article	Year
Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure. ESC heart failure, 2018, Volume: 5, Issue:5 Topics: Aged; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Prognosis; Prospective Studies; Severity of Illness Index; Ventricular Remodeling	2018
Relationship between non-osmotic arginine vasopressin secretion and hemoglobin A1c levels in adult patients with congenital heart disease. Heart and vessels, 2019, Volume: 34, Issue:5 Topics: Adult; Arginine Vasopressin; Biomarkers; Diabetes Mellitus, Type 2; Disease Progression; Female; Glycated Hemoglobin; Heart Defects, Congenital; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Natriuretic Peptide, Brain; Young Adult	2019
Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD). Clinical and experimental nephrology, 2015, Volume: 19, Issue:6 Topics: Adult; Aged; Arginine Vasopressin; Biomarkers; Body Mass Index; Cyclic AMP; Disease Progression; Female; Glomerular Filtration Rate; Glycopeptides; Humans; Kidney; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Renal Insufficiency, Chronic; Reproducibility of Results	2015
Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease. PloS one, 2016, Volume: 11, Issue:2 Topics: Animals; Arginine Vasopressin; Chromosomes, Artificial, Bacterial; Circadian Rhythm; Disease Models, Animal; Disease Progression; Female; Founder Effect; Gene Expression; Humans; Huntington Disease; Male; Mice; Mice, Transgenic; Motor Activity; Rotarod Performance Test; Sex Factors; Suprachiasmatic Nucleus; Time Factors; Vasoactive Intestinal Peptide	2016
Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1. Journal of clinical immunology, 2016, Volume: 36, Issue:2 Topics: Adrenomedullin; Adult; Angioedemas, Hereditary; Arginine Vasopressin; Cardiovascular Diseases; Case-Control Studies; Complement C1 Inhibitor Protein; Disease Progression; Endothelin-1; Female; Hereditary Angioedema Types I and II; Humans; Male; Middle Aged; Risk Factors; Young Adult	2016
Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2017, 01-01, Volume: 32, Issue:suppl_1 Topics: Adult; Arginine Vasopressin; Biomarkers; Creatinine; Disease Progression; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Glycopeptides; Humans; Kidney Function Tests; Male; Middle Aged; Prognosis; Prospective Studies; Severity of Illness Index	2017
Thermoregulation and vasopressin secretion during polymicrobial sepsis. Neuroimmunomodulation, 2009, Volume: 16, Issue:1 Topics: Animals; Arginine Vasopressin; Blood Pressure; Body Temperature Regulation; Disease Models, Animal; Disease Progression; Hypotension; Hypothalamus; Laparotomy; Male; Mortality; Nitric Oxide; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Sepsis; Shock, Septic; Supraoptic Nucleus; Up-Regulation	2009
Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:5 Topics: Angiotensin II; Animals; Arginine Vasopressin; Butadienes; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Male; MAP Kinase Kinase Kinases; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitriles; Nitroarginine; Nitroprusside; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Piperidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Vasoconstriction; Vasodilation	2009
Vasopressin in chronic kidney disease: an elephant in the room? Kidney international, 2009, Volume: 76, Issue:9 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Chronic Disease; Disease Progression; Drug Therapy, Combination; Hormone Antagonists; Humans; Kidney; Kidney Diseases; Proteinuria; Rats; Receptors, Vasopressin; Renin-Angiotensin System; Signal Transduction; Time Factors; Treatment Outcome	2009
Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure. Circulation. Heart failure, 2012, Jul-01, Volume: 5, Issue:4 Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Blood Pressure; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Heart Failure; Hormone Antagonists; Hypertension; Kidney; Kidney Diseases; Male; Myocardium; Natriuretic Peptides; Rats; Rats, Inbred Dahl; Receptors, Vasopressin; RNA, Messenger; Sodium Chloride, Dietary; Time Factors; Tolvaptan; Ultrasonography; Urination; Ventricular Dysfunction, Left; Ventricular Function, Left	2012
Hyponatremia and outcomes in patients with heart failure. Heart (British Cardiac Society), 2012, Volume: 98, Issue:24 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Progression; Global Health; Heart Failure; Humans; Hyponatremia; Incidence; Prognosis; Sodium; Survival Rate; Tolvaptan	2012
The clinical effects of vasopressin receptor antagonists in heart failure. Cleveland Clinic journal of medicine, 2006, Volume: 73 Suppl 2 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Biomarkers; Disease Progression; Heart Failure; Hemodynamics; Humans; Hyponatremia; Prognosis; Receptors, Vasopressin	2006
Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock. Critical care medicine, 2007, Volume: 35, Issue:10 Topics: Aged; Arginine Vasopressin; Disease Progression; Female; Humans; Male; Retrospective Studies; Shock; Vasoconstrictor Agents; Vasodilation	2007
Neurohumoral variability in left ventricular dysfunction. SOLVD Investigators. Studies of Left Ventricular Dysfunction. The American journal of cardiology, 1995, Feb-15, Volume: 75, Issue:5 Topics: Aged; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Disease Progression; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Randomized Controlled Trials as Topic; Renin; Supine Position; Ventricular Dysfunction, Left	1995
Molecular aspects of the pathogenesis involved in the development of familial central diabetes insipidus. Internal medicine (Tokyo, Japan), 1998, Volume: 37, Issue:9 Topics: Adolescent; Animals; Arginine Vasopressin; Diabetes Insipidus; Disease Progression; Exons; Genes, Dominant; Humans; Male; Point Mutation; Protein Precursors; Rats; Rats, Brattleboro; Vasopressins	1998
Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats. Life sciences, 1999, Volume: 65, Issue:10 Topics: Animals; Arginine Vasopressin; Blood Pressure; Body Weight; Creatinine; Diabetes Insipidus; Disease Models, Animal; Disease Progression; Kidney; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Uremia; Vasopressins	1999
Renal endothelin in heart failure and its relation to sodium excretion. American heart journal, 2000, Volume: 140, Issue:4 Topics: Aged; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Circadian Rhythm; Disease Progression; Endothelin-1; Female; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Radioimmunoassay; Renin; Severity of Illness Index; Sodium; Survival Rate	2000
Water metabolism disturbances at different stages of primary thyroid failure. The Journal of endocrinology, 2001, Volume: 168, Issue:3 Topics: Adolescent; Adult; Aged; Aldosterone; Analysis of Variance; Arginine Vasopressin; Disease Progression; Female; Humans; Hypothyroidism; Male; Middle Aged; Osmolar Concentration; Renin; Saline Solution, Hypertonic; Thirst; Water	2001